Does Bovie Medical Corporation (NYSEMKT:BVX) Have Gas After Even Less Sellers Involved?

September 17, 2017 - By Vivian Currie

 Does Bovie Medical Corporation (NYSEMKT:BVX) Have Gas After Even Less Sellers Involved?

Investors sentiment decreased to 1.53 in 2016 Q4. Its down 0.91, from 2.44 in 2016Q3. It worsened, as 9 investors sold Bovie Medical Corporation shares while 6 reduced holdings. 11 funds opened positions while 12 raised stakes. 9.00 million shares or 42.24% more from 6.33 million shares in 2016Q3 were reported.
Driehaus Mgmt Ltd Liability accumulated 0.07% or 521,516 shares. Prelude Cap Mgmt Limited accumulated 8,089 shares or 0% of the stock. Globeflex Cap L P owns 200 shares. Thompson Davis Com Inc invested in 0.01% or 2,000 shares. 103,728 are held by Geode Capital Limited Liability Co. Manatuck Hill Prtnrs Ltd Com owns 125,000 shares. Kcg Inc holds 33,527 shares. 123,000 are owned by Pura Vida Ltd Com. Atria Ltd Liability Corporation holds 0% in Bovie Medical Corporation (NYSEMKT:BVX) or 10,000 shares. California Public Employees Retirement Sys accumulated 28,177 shares or 0% of the stock. 330,800 were accumulated by Renaissance Technology. Deutsche Financial Bank Ag has invested 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX). 500,000 are owned by Emerald Mutual Fund Advisers. Blackrock Fund Advsrs has invested 0% in Bovie Medical Corporation (NYSEMKT:BVX). Morgan Stanley reported 0% in Bovie Medical Corporation (NYSEMKT:BVX).

The stock of Bovie Medical Corporation (NYSEMKT:BVX) registered a decrease of 9.8% in short interest. BVX’s total short interest was 129,800 shares in September as published by FINRA. Its down 9.8% from 143,900 shares, reported previously. With 101,500 shares average volume, it will take short sellers 1 days to cover their BVX’s short positions. The short interest to Bovie Medical Corporation’s float is 0.56%.

The stock increased 10.53% or $0.3 on September 15, reaching $3.15. About 257,813 shares traded or 25.30% up from the average. Bovie Medical Corporation (NYSEMKT:BVX) has risen 28.74% since September 17, 2016 and is uptrending. It has outperformed by 12.04% the S&P500.

Bovie Medical Corporation is an energy medical device company. The company has market cap of $97.21 million. The Firm is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It currently has negative earnings. It operates through three divisions: Core, OEM and J-Plasma.

More notable recent Bovie Medical Corporation (NYSEMKT:BVX) news were published by: Seekingalpha.com which released: “Bovie Medical’s Turnaround Is Here” on March 01, 2016, also Seekingalpha.com with their article: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q4 2016 Results …” published on March 10, 2017, Businesswire.com published: “Bovie Medical Receives 510K Clearance for Its Cool-Coagâ„¢ Generator and Open …” on March 27, 2017. More interesting news about Bovie Medical Corporation (NYSEMKT:BVX) were released by: Businesswire.com and their article: “Bovie Medical Announce Sales Channel Partnership with CONMED for PlazXactâ„¢” published on January 19, 2017 as well as Streetinsider.com‘s news article titled: “Form 8-K BOVIE MEDICAL Corp For: Sep 15” with publication date: September 15, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.